SCHEMBL137358

SCHEMBL137358

CCC1=C(CC)C(=O)OC1=O

nearest known ligand 0.38

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 7/20 0.38
CDC25B P30305 7/20 0.38
CDC25C P30307 6/20 0.38
ALOX15 P16050 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
XIAP P98170 1/20 0.31
TSHR P16473 2/20 0.30
ALDH1A1 P00352 1/20 0.30
FGFR1 P11362 1/20 0.30
FGFR2 P21802 1/20 0.30
FGFR4 P22455 1/20 0.30
FGFR3 P22607 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22654548 1.00 CDC25A (0.38) CDC25ACDC25BCDC25CALOX15TDP1
SCHEMBL12393814 0.87 CDC25A (0.44) CDC25ACDC25BCDC25C
SCHEMBL3292856 0.83 CDC25A (0.33) CDC25ACDC25BCDC25C
SCHEMBL2662258 0.83 CDC25A (0.55) CDC25ACDC25BCDC25CTDP1ALDH1A1
SCHEMBL16446391 0.81 ALDH1A1 (0.35) CDC25ACDC25BCDC25CTSHRALDH1A1
SCHEMBL11807986 0.81 CDC25A (0.30) CDC25ACDC25BCDC25C
SCHEMBL14029273 0.78 CDC25A (0.69) CDC25ACDC25BCDC25CTDP1TSHR
SCHEMBL304780 0.78 TP53 (0.44)
SCHEMBL305040 0.72 MAP2K7 (0.35) CDC25ACDC25B
SCHEMBL306205 0.71 ADCY1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 425 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388744-A1 HALOGEN FREE AND PHOSPHORUS FREE LOW LOSS FLAME RETARDANT COMPOSITIONS CONTAINING POLYCYCLIC-OLEFINIC POLYMER WITH OLEFINIC AND ANHYDRIDE FUNCTIONALITY AND MELAMINE PROMERUS, LLC (US) 2025-12-25 US claimed
US-12275822-B2 Foam, composite material, and foaming composition INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2025-04-15 US claimed
EP-4437600-A1 ACRYLATE BINDER Solvay Specialty Polymers Italy S.p.A. (IT) 2024-10-02 EP claimed
CN-118575292-A Acrylic ester binder 索尔维特殊聚合物意大利有限公司 2024-08-30 CN claimed
EP-3345930-B1 DEVICE FOR CONTINUOUSLY PRODUCING CHEMICALLY-MODIFIED CELLULOSE AND METHOD USED IN SAME JAPAN STEEL WORKS LTD (JP) 2024-06-26 EP claimed
US-20230374666-A1 METAL SURFACE TREATMENT RHODIA OPERATIONS (FR) 2023-11-23 US claimed
US-20230374336-A1 METAL SURFACE TREATMENT RHODIA OPERATIONS (FR) 2023-11-23 US claimed
EP-4225864-A1 METAL SURFACE TREATMENT RHODIA OPERATIONS (FR) 2023-08-16 EP claimed
EP-4225856-A1 METAL SURFACE TREATMENT RHODIA OPERATIONS (FR) 2023-08-16 EP claimed
CN-116355408-A Foam, composite material, and foam composition 财团法人工业技术研究院 2023-06-30 CN claimed
WO-2013060806-A1 ADHESIVE PASTE WITH INCREASED TEMPERATURE STABILITY AND USE THEREOF FOR AN ADHESIVE TAPE TESA SE (DE) 2013-05-02 WO claimed
US-20120197000-A1 HIGH REFRACTIVE POLYMERS, OPTICAL ELEMENTS, AND PHOTOELECTRIC DEVICE EMPLOYING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2012-08-02 US claimed
EP-1851544-A4 COMPOSITIONS AND METHODS FOR THE REVERSIBLE CAPTURE OF BIOMOLECULES UNIV CARNEGIE MELLON (US) 2008-12-10 EP claimed
US-20070287828-A1 Compositions and Methods for the Reversible Capture of Biomolecules CARNEGIE MELLON UNIVERSITY 2007-12-13 US claimed
EP-1851544-A1 COMPOSITIONS AND METHODS FOR THE REVERSIBLE CAPTURE OF BIOMOLECULES Carnegie Mellon University (US) 2007-11-07 EP claimed
EP-1567862-A4 COMPOSITIONS AND METHODS FOR THE REVERSIBLE CAPTURE OF BIOMOLECULES UNIV CARNEGIE MELLON (US) 2007-04-18 EP claimed
WO-2006091183-A1 COMPOSITIONS AND METHODS FOR THE REVERSIBLE CAPTURE OF BIOMOLECULES CARNEGIE MELLON UNIVERSITY (US) 2006-08-31 WO claimed
EP-1567862-A2 COMPOSITIONS AND METHODS FOR THE REVERSIBLE CAPTURE OF BIOMOLECULES CARNEGIE-MELLON UNIVERSITY (US) 2005-08-31 EP claimed
US-20040152880-A1 Compositions and methods for the reversible capture of biomolecules CARNEGIE MELLON UNIVERSITY 2004-08-05 US claimed
WO-2004048530-A2 COMPOSITIONS AND METHODS FOR THE REVERSIBLE CAPTURE OF BIOMOLECULES CARNEGIE MELLON UNIVERSITY (US) 2004-06-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388744-A1 HALOGEN FREE AND PHOSPHORUS FREE LOW LOSS FLAME RETARDANT COMPOSITIONS CONTAINING POLYCYCLIC-OLEFINIC POLYMER WITH OLEFINIC AND ANHYDRIDE FUNCTIONALITY AND MELAMINE PYM1, TAAR1, RAD52 CDC25A 388/4885CDC25B 460/4885CDC25C 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.